National Cancer Institute; Notice of Closed Meetings, 3642 [2011-1150]

Download as PDF 3642 Federal Register / Vol. 76, No. 13 / Thursday, January 20, 2011 / Notices 17, 2011, 3 p.m., Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852 which was published in the Federal Register on January 5, 2011, 76 FR 577. This notice is amending the start time of the meeting from 1 p.m. to 8:30 a.m. The meeting is closed to the public. Dated: January 13, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–1151 Filed 1–19–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings mstockstill on DSKH9S0YB1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, Innovative and Early Stage Development of Emerging Technologies in Biospecimen Science. Date: February 24, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Donald L. Coppock, PhD, Scientific Review Officer, Scientific Review and Logistic Branch, Division of Extramural Activities, NCI, National Institutes of Health, 6116 Executive Blvd., Rm 7151, Bethesda, MD 20892. 301–451–9385. coppockdl@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Radioprotector/Mitigator Development for Radiotherapy. Date: February 24–25, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. VerDate Mar<15>2010 18:24 Jan 19, 2011 Jkt 223001 Contact Person: Viatcheslav A. Soldatenkov, M.D., PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd Room 8057, Bethesda, MD 20892–8329. 301–451– 4758. soldatenkovv@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Creating Interdisciplinary Research Teams in Basic Behavioral and Social Science Research. Date: March 7, 2011. Time: 8:30 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Ellen K Schwartz, EDD, MBA, Scientific Review Officer, Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8055B, Bethesda, MD 20892–8329. 301–594–1215. schwarel@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Cancerrelated Applications for Conferences and Scientific Meetings. Date: March 7, 2011. Time: 3 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Ellen K Schwartz, EDD, MBA, Scientific Review Officer, Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8055B, Bethesda, MD 20892–8329. 301–594–1215. schwarel@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Novel Imaging Agents to Expand the Clinical Toolkit for Cancer Diagnosis, Staging and Treatment. Date: March 8, 2011. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate contract proposals. Place: The Legacy Hotel, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Savvas C Makrides, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm 8050a, Bethesda, MD 20892. 301–496–7421. makridessc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Cancer Prevention Research Small Grant Program (R03). Date: March 10–11, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance M Street Hotel. 1143 New Hampshire Avenue, NW., Washington, DC 20037. Contact Person: Irina Gordienko, PhD, Scientific Review Officer, Scientific Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm. 7073, Bethesda, PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 MD 20892. 301–594–1566. gordienkoiv@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Emerging Technologies for Cancer Research. Date: March 29–30, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Viatcheslav A. Soldatenkov, M.D., PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd Room 8057, Bethesda, MD 20892–8329. 301–451– 4758. soldatenkovv@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: January 13, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–1150 Filed 1–19–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Human Genome Research Institute Special Emphasis Panel, KOMP (KNOCK-OUT MOUSE PROJECT). Date: February 16, 2011. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Crystal Gateway Marriott, 1700 Jefferson Davis Highway, Arlington, VA 22202. E:\FR\FM\20JAN1.SGM 20JAN1

Agencies

[Federal Register Volume 76, Number 13 (Thursday, January 20, 2011)]
[Notices]
[Page 3642]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-1150]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Innovative and Early Stage Development of Emerging 
Technologies in Biospecimen Science.
    Date: February 24, 2011.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Donald L. Coppock, PhD, Scientific Review 
Officer, Scientific Review and Logistic Branch, Division of 
Extramural Activities, NCI, National Institutes of Health, 6116 
Executive Blvd., Rm 7151, Bethesda, MD 20892. 301-451-9385. 
coppockdl@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Radioprotector/Mitigator Development for Radiotherapy.
    Date: February 24-25, 2011.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Viatcheslav A. Soldatenkov, M.D., PhD, 
Scientific Review Officer, Special Review and Logistics Branch, 
Division of Extramural Activities, National Cancer Institute, 6116 
Executive Blvd Room 8057, Bethesda, MD 20892-8329. 301-451-4758. 
soldatenkovv@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Creating Interdisciplinary Research Teams in Basic Behavioral 
and Social Science Research.
    Date: March 7, 2011.
    Time: 8:30 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Ellen K Schwartz, EDD, MBA, Scientific Review 
Officer, Special Review & Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8055B, Bethesda, MD 20892-8329. 301-594-1215. 
schwarel@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Cancer-related Applications for Conferences and Scientific 
Meetings.
    Date: March 7, 2011.
    Time: 3 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Ellen K Schwartz, EDD, MBA, Scientific Review 
Officer, Special Review & Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8055B, Bethesda, MD 20892-8329. 301-594-1215. 
schwarel@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Novel Imaging Agents to Expand the Clinical Toolkit for 
Cancer Diagnosis, Staging and Treatment.
    Date: March 8, 2011.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: The Legacy Hotel, 1775 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Savvas C Makrides, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm 
8050a, Bethesda, MD 20892. 301-496-7421. makridessc@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Cancer Prevention Research Small Grant Program (R03).
    Date: March 10-11, 2011.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Renaissance M Street Hotel. 1143 New Hampshire Avenue, 
NW., Washington, DC 20037.
    Contact Person: Irina Gordienko, PhD, Scientific Review Officer, 
Scientific Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., 
Rm. 7073, Bethesda, MD 20892. 301-594-1566. 
gordienkoiv@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Emerging Technologies for Cancer Research.
    Date: March 29-30, 2011.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Viatcheslav A. Soldatenkov, M.D., PhD, 
Scientific Review Officer, Special Review and Logistics Branch, 
Division of Extramural Activities, National Cancer Institute, 6116 
Executive Blvd Room 8057, Bethesda, MD 20892-8329. 301-451-4758. 
soldatenkovv@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 13, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-1150 Filed 1-19-11; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.